Ari Fried is a partner at Gornitzky GNY.
Before joining the firm in 2008, Ari was a senior associate at another leading Israeli law firm. Ari was born and raised in Montreal, Canada, and moved to Israel in 1998.
Ari’s practice focuses primarily on corporate finance, capital markets, and mergers and acquisitions in transactions involving both privately-held and publicly-traded Israeli and multinational corporations.
Ari has represented public and private buyers and sellers in domestic and cross-border mergers and acquisitions, issuers and underwriters in equity and debt offerings in the United States and in Israel (both public offerings and private placements), and lenders and borrowers in debt financings. Ari also advises clients on day-to-day corporate matters.
Representative transactions include:
- Representing an Israeli company in its USD 75 million IPO on Nasdaq.
- Representing a U.S. medical device and software solutions company in its USD 538 million acquisition of an Israeli medical device company traded on Nasdaq and the Tel Aviv Stock Exchange.
- Representing underwriters in a USD 459 million follow-on and secondary offering of shares of an Israeli company traded on Nasdaq.
- Representing underwriters in a USD 883 million secondary offering of shares of an Israeli company traded on Nasdaq.
- Representing underwriters in a USD 287 million IPO on Nasdaq of an Israeli company.
- Representing underwriters in a USD 631 million IPO on Nasdaq of an Israeli company.
- Representing underwriters in a USD 431 million IPO on Nasdaq of an Israeli company.
- Representing underwriters in a USD 176 million IPO on Nasdaq of an Israeli company.
- Representing a U.S NASDAQ-traded SPAC in its business combination with an Israeli company traded on Tel Aviv Stock Exchange.
- Representing underwriters in a USD 172.5 million follow-on offering on Nasdaq by an Israeli company.
- Representing a NYSE-traded company in its acquisition of an Israeli company traded on the Tel Aviv Stock Exchange for $7.1 billion.
- Representing an Israeli real estate company traded on the Tel Aviv Stock Exchange in its acquisition by a German company traded on the Frankfurt Stock Exchange for over 708 million Euros.
- Representing underwriters in a USD 151 million secondary offering on Nasdaq of shares of an Israeli company listed on Nasdaq.
- Representing underwriters in a USD 71 million IPO on Nasdaq of an Israeli company.
- Representing underwriters in a USD 59 million IPO on Nasdaq of an Israeli company listed on the Tel Aviv Stock Exchange.
- Representing underwriters in a USD 72.5 million follow-on offering on Nasdaq by an Israeli company listed on Nasdaq and the Tel Aviv Stock Exchange.
- Representing a private equity firm in its USD 168 million sale of its shares of an Israeli company in an underwritten secondary offering on Nasdaq.
- Representing a publicly traded Israeli oil company in a USD 600 million debt financing transaction from a consortium of Israeli banks and financial institutions and in a USD 300 million debt financing transaction from a US bank.
- Representing a publicly traded Israeli-based international food and beverage company in a spin-off of a portion of its business and a simultaneous USD 295 million investment by a top-tier international private equity fund.
- Representing a Canadian real estate company in its IPO on the Tel Aviv Stock Exchange that involved a simultaneous reorganization of its assets.
- Representing a Canadian real estate company in a public debt offering on the Tel Aviv Stock Exchange in which it raised approximately NIS 178 million.
- Representing underwriters in a USD 100 million secondary offering on Nasdaq of shares of an Israeli company listed on both Nasdaq and the Tel Aviv Stock Exchange.
- Representing the controlling shareholder of a leading Israeli media company in the sale of fifty percent of his shares to a strategic investor.
- Representing an Israeli publicly traded company in the acquisition by its subsidiary of the assets of a Romanian company.
- Representing a multinational bank in a USD 200 million revolving loan agreement with an Israeli publicly traded company.
